We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

2 hedge funds and large institutions have $4.55K invested in Vigil Neuroscience in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 76 closing their positions.

New
Increased
Maintained
Reduced
Closed

71.57% less ownership

Funds ownership: 71.63% → 0.06% (-72%)

97% less funds holding

Funds holding: 78 → 2 (-76)

100% less funds holding in top 10

Funds holding in top 10: 4 → 0 (-4)

100% less capital invested

Capital invested by funds: $266M → $4.55K (-$266M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 76

Holders
2
Holders Change
-76
Holders Change %
-97.44%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
76
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$119K

Top Sellers

Rank Fund Capital Flow
1
AVLSA
Atlas Venture Life Science Advisors
Massachusetts
-$46.4M
2
BCM
Beryl Capital Management
California
-$36.6M
3
GCL
Glazer Capital LLC
New York
-$23.9M
4
OBAM
ODDO BHF Asset Management
France
-$18.3M
5
6CM
683 Capital Management
New York
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
PD
76
Point72 (DIFC)
United Arab Emirates
– -$47 -6 Closed
SS
77
SBI Securities
Japan
– -$8 -1 Closed
XT
78
XTX Topco
Cayman Islands
– +$119K +14,771 +128%
1 2 3
4

VIGL Hedge Fund Activity: Q3 2025 in Review

2 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q3 2025, worth a combined $4.55K — down 100% from $266M a quarter earlier.

Sellers outnumbered buyers: 76 funds closed out of VIGL and 0 opened new positions — a net loss of 76 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was XTX Topco, adding an estimated $119K. The largest seller was Atlas Venture Life Science Advisors, exiting entirely with an estimated $46.4M sold.

  • 2 institutional investors held Vigil Neuroscience (VIGL) as of Q3 2025, down from 78 in Q2 2025.
  • Funds reported $4.55K of Vigil Neuroscience stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Vigil Neuroscience positions in Q3 2025 and 76 closed out, a net change of -76 holders.
  • The largest Vigil Neuroscience buyer in Q3 2025 was XTX Topco, an estimated $119K added.
  • The largest Vigil Neuroscience seller in Q3 2025 was Atlas Venture Life Science Advisors, an estimated $46.4M sold.

Based on aggregated 13F filings for Q3 2025.